DiaMedica makes board appointment
This article was originally published in Scrip
Executive Summary
DiaMedica (Canada) has appointed Dr Michael Giuffre to its board of directors. Dr Giuffre is a clinical professor of cardiac sciences and paediatrics at the University of Calgary and is also a member on the boards of the Alberta Medical Association and Unicef Canada. DiaMedica is a biopharmaceutical company focused on the development of treatments for diabetes and neurological disorders.